Serina Therapeutics Showcases Innovations at the Injectables Summit
Innovation in Drug Delivery at the Injectables Summit
Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER) is making waves in the biotechnology field with its groundbreaking POZ Platform technology. This innovative drug delivery method aims to improve the lives of patients suffering from neurological diseases. At a recent prestigious event, the 14th Annual Injectables Summit, Serina's Chief Development Officer, Randall Moreadith, MD, PhD, took the stage alongside Enable Injections’ Chief Commercial Officer, Matthew Huddleston, to present their collaborative efforts in advancing patient care.
Collaboration for Advanced Parkinson's Disease
The joint presentation titled, “Patient-enabled Therapy for Advanced Parkinson's Disease - A Case Study with Serina Therapeutics' SER-252 + Enable Injections' enFuse Wearable Drug Delivery Platform” highlighted how both companies are working together to develop effective and patient-friendly therapeutics. Their unique approach focuses on enhancing drug delivery methods that are both comfortable and convenient for those living with advanced Parkinson's Disease, aiming to significantly improve the quality of life for these individuals.
About Serina Therapeutics and Its Mission
Serina is dedicated to developing a range of proprietary drug product candidates, targeting neurological diseases and other significant health issues. The company's POZ Platform technology is not only innovative but holds great promise for the future of drug delivery. This cutting-edge platform aims to enhance the efficacy and safety of various treatment modalities, including small molecules, RNA-based therapeutics, and antibody-drug conjugates (ADCs), paving the way for potentially transformative therapies.
Headquarters and Future Vision
Located on the campus of the HudsonAlpha Institute of Biotechnology in Huntsville, Alabama, Serina operates in a thriving environment conducive to innovation and scientific advancement. The organization emphasizes research and development to drive its vision forward, focusing on unlocking new potentials in drug delivery and treatment efficacy.
Contact Information for Inquiries
For anyone interested in learning more about Serina Therapeutics or their current projects, inquiries can be directed to their investor relations team. They can be reached via email at Investor.relations@serinatherapeutics.com or by phone at (256) 327-9630.
Frequently Asked Questions
What is the POZ Platform technology?
The POZ Platform is a proprietary drug delivery technology developed by Serina Therapeutics that aims to enhance the efficacy and safety of various therapeutic modalities.
Who presented at the Injectables Summit?
Randall Moreadith, MD, PhD, from Serina Therapeutics and Matthew Huddleston from Enable Injections collaborated on a presentation about advanced Parkinson's disease.
What is the focus of Serina Therapeutics?
Serina Therapeutics focuses on developing drug products targeting neurological diseases and improving therapeutic delivery methods.
Where is Serina Therapeutics based?
Serina Therapeutics is located in Huntsville, Alabama, at the HudsonAlpha Institute of Biotechnology.
How can I contact Serina Therapeutics?
You can contact Serina Therapeutics via email at Investor.relations@serinatherapeutics.com or by calling (256) 327-9630.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Understanding the Recent Trends Around Rambus and Market Sentiment
- Transformative Dental Solutions: Hybridge Expands into New Region
- Innovative Partnership to Enhance Sports Investment Access
- Exploring the Growing Prospects in Regenerative Medicine
- Strategic Alliance Between Pearson and Degreed for Skill Development
- Record Growth in Crude Oil Weekly Options At CME Group
- Marinus Pharmaceuticals Secures Major Patent Victory for Innovation
- KeyBanc Maintains Sector Weight Rating on Comfort Systems
- North Haven Fund Issues $300M Senior Notes to Strengthen Capital
- Tesla's Latest Performance: Key Insights on Deliveries and Growth
Recent Articles
- Five Below's Stock Surge: Analyst Insights on Future Growth
- Remarkable Growth of Oliveda's Olive Tree People Subsidiary
- Introducing The Frame Astoria: A New Era in Chic Living
- RTI International Launches Initiative for Lead-Free Futures
- KULR Technology Group Makes Waves With $2.35 Million Deal
- Organic Fertilizer Market Set to Thrive with USD 15B Potential
- Star Equity Holdings' Subsidiary Lands $4.6M Housing Contracts
- Machine Safety Market Forecast: Growth and Key Players Ahead
- Kroger Co Enhances Exchange Offers for Albertsons Company Notes
- Electric Motors Market Set for Remarkable Growth by 2029
- NeoVolta Builds Stronger Dealer Network with $1.4 Million Deal
- US Dollar Outlook: Steady Amid Fed Rate Cuts and Global Risks
- Black Hills Corp. Gains Approval for Arkansas Natural Gas Rates
- Top Food Delivery Companies in Europe: Insights from Analysts
- Enovix Launches First Battery Cell Shipments from Malaysia
- Nikola Reports 22% Increase in Hydrogen Truck Deliveries
- Innovative Strategies by Annovis Bio Inc. in Alzheimer's Research
- Lucent, Inc. Advances AI in Energy Storage Solutions
- OneMedNet Enhances Board to Propel Growth After IPO Success
- Elevai Skincare's Innovative Clinical Study for Skin Rejuvenation
- Liberty Star Secures $10 Million Financing to Fuel Exploration
- KULR Technology Unveils Major Licensing Breakthrough with Japan
- Femasys Enhances Infertility Care Through New Orders in Europe
- Skyward Specialty Insurance Enhances Renewable Energy Options
- SEALSQ to Present Innovative Secure Chip at CEATEC 2024
- Humana Inc. Faces Major Challenges After Rating Decline
- Reviva Pharmaceuticals Set to Engage at Upcoming Healthcare Conference
- TerraZero Launches Innovative iGaming Tech for Better Engagement
- Fiverr Set to Share Q3 Financial Insights This October
- Inspired Entertainment Unveils Innovative Hybrid Roulette Game
- Star Equity Holdings Secures $4.6 Million Building Contracts
- Yoshiharu's $1 Million Investment Fuels Korean BBQ Expansion
- Bill Smith’s $3 Million Investment Fortifies Smith Micro’s Future
- Petszel: Revolutionizing Post-Adoption Support for Shelters
- Banzai Secures Nasdaq Extension to Meet Compliance Goals
- Marriott Vacations Plans Exciting Earnings Call This November
- NETSOL Partners with Hiltermann to Enhance European Operations
- Key Factors for Manufacturers Choosing Vendors in Technology
- Align Technology Prepares to Share Q3 Financial Results Soon
- Exciting Leadership Changes at dancker with New CFO
- Cleveland Launches Innovative AI-Driven Security System
- MaxLinear to Discuss Q3 2024 Results on Upcoming Call
- Valor Receives Esteemed 2024 Fortune Best Workplaces Honor
- F45 Training Partners with ACS for Fitness and Cancer Awareness
- Colgate University Achieves Historic Repatriation with Piscataway Nation
- Walmart Enhances Health Benefits for Cancer Care Nationwide
- Celebrating Leadership: The 2024 Toby Merrill Award Winners
- Explore Opportunities in Distressed Real Estate Through Webinar
- Armitron Unveils New Together In Pink Collection for Awareness
- ISG Strengthens Focus with Sale of Automation Division